Pearl River Capital, LLC Enovis Corp Transaction History

Pearl River Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$44.56 - $62.43 $531,244 - $744,290	11,922 New	11,922 $538,000
Q1 2023 May 12, 2023	SELL	$49.5 - $65.92 $91,624 - $122,017	-1,851 Reduced 27.26%	4,940 $264,000
Q4 2022 Feb 13, 2023	SELL	$44.83 - $57.43 $82,935 - $106,245	-1,850 Reduced 21.41%	6,791 $363,000
Q3 2022 Nov 14, 2022	BUY	$46.07 - $60.1 $22,896 - $29,869	497 Added 6.1%	8,641 $398,000
Q2 2022 Aug 12, 2022	BUY	$55.0 - $70.47 $447,920 - $573,907	8,144 New	8,144 $448,000

310

60.3M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.53B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.